Epidemiology, Significance and Clinical Outcomes of Bloodstream Infections Caused by Non‐ <i>Candida</i> and Non‐ <i>Cryptococcus</i> Yeasts
Although rare, fungaemia due to non-Candida and non-Cryptococcus yeasts is associated with significant mortality and antifungal resistance. Species identification and susceptibility testing are crucial to guide treatment. Increased awareness is essential in high-risk patients, particularly those with malignancy, heart failure, or requiring ICU admission.
Authors
- Kevin B. Laupland (ORCID: https://orcid.org/0000-0002-1205-5354)
- Adam G. Stewart (ORCID: https://orcid.org/0000-0002-7262-7529)
- Monica A. Slavin (ORCID: https://orcid.org/0000-0002-8443-314X)
- Sharon C.‐A. Chen (ORCID: https://orcid.org/0000-0002-9983-6603)
- Felicity Edwards (ORCID: https://orcid.org/0000-0002-9896-841X)
Institutions
- The University of Sydney (AU)
- Harvard University (US)
- Queensland University of Technology (AU)
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Royal Brisbane and Women's Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- Taronga Conservation Society Australia (AU)
- Westmead Hospital (AU)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Mycoses
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1111/myc.70093
- Citations
- 2
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Strong